Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Debt / NOTE 4.500% 7/1
-
Number of holders
-
15
-
Total principal
-
117M
-
Principal change
-
+155K
-
Total reported value, excl. options
-
$234M
-
Value change
-
+$2.1M
-
Number of buys
-
6
-
Number of sells
-
-7
-
Price
-
$2.00
Significant Holders of MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 as of Q1 2015
14 filings reported holding 590328AA8 - MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 as of Q1 2015.
MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 has 15 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $117M of principal
.
Largest 10 bondholders include Citadel Advisors LLC ($32.2M of principal), Polygon Management Ltd. ($17.4M of principal), SILVERBACK ASSET MANAGEMENT LLC ($15.2M of principal), WOLVERINE ASSET MANAGEMENT LLC ($12.6M of principal), ARISTEIA CAPITAL LLC ($10.9M of principal), TANG CAPITAL MANAGEMENT LLC ($5.5M of principal), JPMORGAN CHASE & CO ($4.5M of principal), PUTNAM INVESTMENTS LLC ($4.01M of principal), CSS LLC/IL ($3.89M of principal), and Polar Capital LLP ($3.65M of principal).
This table shows the top 15 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.